3X GREATER ABSORPTION FISH OIL*
Omega MonoPure® 1300 EC features natural enzymatically enhanced MaxSimil® monoglyceride fish oil that has a three times greater EPA/DHA absorption rate than an equivalent dose of ethyl ester fish oil. This IFOS five-star certified fish oil outperforms other fish oil supplements through MaxSimil patented lipid absorption enhancement technology (PLATform).*
Why This Formula
- Positively Affects the Production of Arachidonic Acid-Derived Eicosanoids*
- Supports Cardiovascular Health*
- Supports Healthy Mental Functioning*
- Supports Healthy Glucose and Insulin Metabolism*
- By Supplying the Precursors EPA and DHA, Helps the Body Generate Specialized Proresolving Lipid Mediators, Such as Resolvins and Protectins*
The MaxSimil PLATform is a novel monoglyceride delivery system that enhances absorption of lipid-based and lipid-soluble nutraceutical and food ingredients.
This technology has been applied to XYMOGEN’s Omega MonoPure formula in order to create a unique vehicle by which to deliver EPA and DHA. Due to the fact that monoglyceride oils are intrinsically emulsifiers and are, by nature, in a readily absorbable form (Figure 1), they can bypass the body’s normal fat digestion process.
These qualities make Omega MonoPure an excellent method for delivering omega-3 fatty acids, especially to individuals with digestive, pancreatic, or gall bladder challenges. Studies show that MaxSimil fish oils (FO) have three times (300%) greater absorption of EPA and DHA compared to other leading fish oils.*
Directions: Take one softgel daily, or use as directed by your healthcare professional. Consult your healthcare professional prior to use. Individuals taking blood thinners or other medication should discuss potential interactions with their healthcare professional Do not use if tamper seal is damaged.
View Clinical Applications/Fact Sheet HERE
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.